Bilophila

Bilophila wadsworthia is a Gram-negative, obligate anaerobic, sulfite-reducing bacterium that has emerged as a key pathobiont linking high-fat diets, taurine metabolism, hydrogen sulfide production, and inflammatory disease. Its unique metabolic niche — using taurine-conjugated bile acids as an electron acceptor — positions it at the intersection of dietary fat intake, bile acid metabolism, and gut inflammation.

Metabolic Specialization

Taurine to H2S Pathway

  • B. wadsworthia metabolizes taurine (from taurine-conjugated bile acids) via taurine dehydrogenase, producing hydrogen sulfide (H2S) as an end product.
  • H2S is genotoxic, inhibits butyrate oxidation in colonocytes, and disrupts the mucus barrier.
  • Taurine-conjugated bile acids increase with high-saturated-fat diets, providing the metabolic substrate that fuels B. wadsworthia expansion.

Hydrogen Utilization

  • Uses H2 as an energy source via hydrogenase enzymes, positioning it within the gut hydrogen economy.
  • H2 consumption by B. wadsworthia can shift the thermodynamics of fermentation by other gut bacteria, influencing overall community metabolism.

Iron and Molybdenum Dependencies

  • The dissimilatory sulfite reductase (DsrAB) that generates H2S contains iron-sulfur clusters, making B. wadsworthia dependent on iron availability.
  • Taurine dehydrogenase requires a molybdenum cofactor, linking its pathogenic metabolism to trace metal availability.

Disease Associations

Colorectal Cancer

  • Significantly more abundant in uninvolved colonic mucosa of CRC cases versus controls among African American/Black individuals [1].
  • H2S production dampens butyrate metabolism in colonocytes, creating a pro-tumorigenic environment.
  • Mediterranean diet intervention aims to reduce B. wadsworthia abundance by shifting bile acid conjugation patterns away from taurine.

Multiple Sclerosis

  • Enriched in MS progressors (patients with worsening disability) and significantly stratifies disease progression risk in Kaplan-Meier analysis [2].
  • As a sulfate-reducing bacterium producing H2S, it may drive oxidative stress and inflammation in the gut brain axis.
  • May thrive in metal-rich environments, connecting MS progression to environmental metal exposure.

Cardiovascular Disease

  • Correlated with altered lipid metabolites (traumatic acid) in viral myocarditis models [3].
  • Hypertension MR studies show decreased Bilophila in hypertensive individuals [4].

IBD

  • Enriched in inflammatory bowel disease, where its H2S production exacerbates mucosal inflammation.
  • Taurine-rich diets (high in animal protein) promote B. wadsworthia expansion and colitis in susceptible hosts.

Other Conditions

  • Arsenic exposure increases Bilophila abundance and perturbs bile acid homeostasis [5].
  • Altered in autism spectrum disorder gut mycobiome-bacteriome interaction studies [6].
  • Decreased in Huntington's disease [7].

Dietary Modulation

The abundance of B. wadsworthia is highly responsive to diet:

  • Increased by: high-saturated-fat diets, high-taurine diets (animal protein), Western-style diets.
  • Decreased by: Mediterranean diet, plant-based diets, high-fiber diets that shift bile acid profiles toward glycine conjugation.

Connections

References (7)

  1. Andrew McLeod, Patricia Wolf, Robert S. Chapkin et al. (2023). Design of the Building Research in CRC Prevention (BRIDGE-CRC) Trial: A 6-Month, Parallel Group Mediterranean Diet and Weight Loss Randomized Controlled Lifestyle Intervention Targeting the Bile Acid-Gut Microbiome Axis to Reduce Colorectal Cancer Risk Among African American/Black Adults with Obesity. Trials
  2. Theresa L. Montgomery, Qin Wang, Ali Mirza et al. (2024). Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis. Scientific Reports. doi:10.1038/s41598-024-64369-x
  3. Yimin Xue, Shirong Lin, Mingguang Chen et al. (2024). Altered colonic microflora and its metabolic profile in mice with acute viral myocarditis induced by coxsackievirus B3. Virology Journal. doi:10.1186/s12985-024-02571-z
  4. Yihui Li, Ru Fu, Ruixuan Li et al. (2023). Causality of gut microbiome and hypertension: A bidirectional mendelian randomization study. Frontiers in Cardiovascular Medicine. doi:10.3389/fcvm.2023.1167346
  5. Qinheng Zhu, Boyan Chen, Fu Zhang et al. (2024). Toxic and Essential Metals: Metabolic Interactions with the Gut Microbiota and Health Implications. Frontiers in Nutrition. doi:10.1016/j.biopha.2023.115602
  6. Francesco Strati, Duccio Cavalieri, Davide Albanese et al. (2017). Strati 2017 — New Evidences on the Altered Gut Microbiota in Autism Spectrum Disorders. Microbiome. doi:10.1186/s40168-017-0242-1
  7. Khatoon S, Kalam N, Rashid S et al. (2023). Effects of gut microbiota on neurodegenerative diseases. Frontiers in Aging Neuroscience. doi:10.2147/DDDT.S580330